The immune destruction of red cells *

It is a great honour that the British Blood Transfusion Society has considered me for the James Blundell Award and I thank the Society very much for this honour. It is also a particular pleasure for me because there has always been a special relationship between the British and Dutch Blood Transfusion Services. This relationship began shortly after World War I1 when my previous boss and friend Joghem van Loghem was invited to the Lister Institute to learn typing for RhD from Ruth Sanger and Rob Race, because discovery of RhD was unknown in occupied Europe until after the war and there was no knowledge of typing for RhD in the Netherlands. Our relations with Rob and Ruth, and also with many other colleagues in the United Kingdom, have had a special quality ever since that first contact.

[1]  W. Ouwehand,et al.  Detection of human monocyte-reactive alloantibodies by flow cytometry after selective downmodulation of the Fc receptor I. , 1991, Blood.

[2]  J. V. D. van de Winkel,et al.  A single amino acid in the second Ig-like domain of the human Fc gamma receptor II is critical for human IgG2 binding. , 1991, Journal of immunology.

[3]  E. Brojer,et al.  Correlation of Monocyte‐Monolayer Assay Results, Number of Erythrocyte‐Bound IgG Molecules, and IgG Subclass Composition in the Study of Red Cell Alloantibodies Other Than D , 1990, Vox sanguinis.

[4]  P. Sims,et al.  The complement-inhibitory activity of CD59 resides in its capacity to block incorporation of C9 into membrane C5b-9. , 1990, Journal of immunology.

[5]  B. Kumpel,et al.  Functional interactions of red cells sensitized by IgG1 and IgG3 human monoclonal anti-D with enzyme-modified human monocytes and FcR-bearing cell lines. , 1990, Molecular immunology.

[6]  W. Ouwehand,et al.  The Fc-receptor III of cultured human monocytes. Structural similarity with FcRIII of natural killer cells and role in the extracellular lysis of sensitized erythrocytes. , 1990, Journal of immunology.

[7]  M. Frank,et al.  High-dose intravenous immunoglobulin modifies complement-mediated in vivo clearance. , 1989, Blood.

[8]  T. Huizinga,et al.  Binding characteristics of dimeric IgG subclass complexes to human neutrophils. , 1989, Journal of immunology.

[9]  D. Burton,et al.  Molecular recognition of antibody (IgG) by cellular Fc receptor (FcRI). , 1988, Molecular immunology.

[10]  Y. Sugita,et al.  Isolation from human erythrocytes of a new membrane protein which inhibits the formation of complement transmembrane channels. , 1988, Journal of biochemistry.

[11]  H. C. Scott,et al.  Differences between the activities of human monoclonal IgG1 and IgG3 anti-D antibodies of the Rh blood group system in their abilities to mediate effector functions of monocytes. , 1988, Immunology.

[12]  G. Mueller‐Eckhardt,et al.  Reduced Immune Phagocytosis of Monocytes from Neonates Whose Mothers Produce HLA Antibodies , 1988, Vox sanguinis.

[13]  S. Clarkson,et al.  CD16. Developmentally regulated IgG Fc receptors on cultured human monocytes , 1988, The Journal of experimental medicine.

[14]  T. Fujita,et al.  The mechanism of action of decay-accelerating factor (DAF). DAF inhibits the assembly of C3 convertases by dissociating C2a and Bb , 1987, The Journal of experimental medicine.

[15]  L. S. Zalman,et al.  Deficiency of the homologous restriction factor in paroxysmal nocturnal hemoglobinuria , 1987, The Journal of experimental medicine.

[16]  M. Witmer,et al.  Blockade of clearance of immune complexes by an anti-F(cγ) receptor monoclonal antibody , 1986, The Journal of experimental medicine.

[17]  R. Kimberly,et al.  Treatment of refractory immune thrombocytopenic purpura with an anti-Fcγ-receptor antibody , 1986 .

[18]  M. Shin,et al.  Homologous species restriction in lysis of human erythrocytes: a membrane-derived protein with C8-binding capacity functions as an inhibitor. , 1986, Journal of immunology.

[19]  P. Capel,et al.  Polymorphism in mitogenic effect of IgG1 monoclonal antibodies against T3 antigen on human T cells , 1983, Nature.

[20]  R. Kurlander.  Blockade of Fc receptor-mediated binding to U-937 cells by murine monoclonal antibodies directed against a variety of surface antigens. , 1983, Journal of immunology.

[21]  E. Baxter,et al.  Chronic hemolytic anemia due to cold agglutinins: a 20-year history of benign gammopathy with response to chlorambucil. , 1973, Blood.

[22]  A. von dem Borne,et al.  Autoimmune haemolytic anaemias. V. studies on the resistance against complement haemolysis of the red cells of patients with chronic cold agglutinin disease. , 1972, Clinical and experimental immunology.

[23]  Dacie Jv,et al.  The in vivo behaviour of complement-coated red cells: studies in C6-deficient, C3-depleted and normal rabbits. , 1970 .

[24]  R. S. Evans,et al.  Chronic hemolytic anemia due to cold agglutinins. II. The role of C' in red cell destruction. , 1968, The Journal of clinical investigation.

[25]  S. L. Lee,et al.  Intravascular erythrophagocytosis. , 1991, JAMA.

[26]  M. Frank,et al.  High doses of intravenous Ig inhibit in vitro uptake of C4 fragments onto sensitized erythrocytes. , 1991, Blood.

[27]  C. Mueller-Eckhardt,et al.  Murine monoclonal antibodies and human alloantisera specific for HLA inhibit monocyte phagocytosis of anti‐D‐sensitized human red blood cells , 1985, European journal of immunology.

[28]  P. Lachmann,et al.  The in vivo behaviour of complement-coated red cells: studies in C6-deficient, C3-depleted and normal rabbits. , 1970, Clinical and experimental immunology.